Clinical and Bacteriologic Characteristics of Six Cases of Bifidobacterium breve Bacteremia Due to Probiotic Administration in the Neonatal Intensive Care Unit
Authors:
- 22 June 2021
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 41 (1) , 62-65
Abstract
Background: Bifidobacterium breve is widely used as a probiotic in preterm infants and children with congenital surgical conditions, however, some cases of probiotics-induced bacteremia have been reported recently. Objectives: To examine the clinical and bacteriologic features of Bifidobacterium breve bacteremia caused by a probiotic (BBG-01) in term and preterm infants. Methods: We included 298 patients who were admitted to the neonatal intensive care unit of Miyagi Children’s Hospital and were given BBG-01 as a probiotic within the period June 2014 to February 2019. We experienced six cases of B. breve bacteremia and assessed their features retrospectively. Results: The incidence rate of B. breve bacteremia in our hospital was 2% (6/298), higher than reported previously. The median age at onset, corrected age, and weight of the patients was 8 days (range: 5–27 days), 35 weeks (range: 26–39 weeks), and 1,940 g (range: 369–2734 g), respectively. The bacteremia triggers were gastrointestinal perforations in two cases, food protein-induced enterocolitis syndrome in two cases, adhesive ileus in one case, ileal volvulus in one case, and aspiration pneumonia following esophageal atresia repair in one case. B. breve was detected on blood cultures after a median of 5 days 13 hours (range: 4 days 18 hours–9 days 13 hours). No patient demonstrated serious symptoms, such as septic shock. All patients received antibiotics and recovered without any sequelae. Conclusions: Ileus and intestinal mucosal damage, such as enteritis, can cause B. breve bacteremia. The incidence of B. breve bacteremia may be higher than reported previously and detection via culture may require a longer time than typically needed for more common bacteria. It is associated with a good prognosis.Keywords
This publication has 12 references indexed in Scilit:
- Bacteremia induced by Bifidobacterium breve in a newborn with cloacal exstrophyPediatrics International, 2016
- Safety of Bifidobacterium breve (BBG‐01) in preterm infantsPediatrics International, 2016
- Intestinal Microbiota in Pediatric Surgical Cases Administered Bifidobacterium BreveJournal of Pediatric Gastroenterology and Nutrition, 2016
- Probiotic Supplementation and Late-Onset Sepsis in Preterm Infants: A Meta-analysisPediatrics, 2016
- Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trialThe Lancet, 2016
- Tolerance of Bifidobacterium human isolates to bile, acid and oxygenAnaerobe, 2013
- Early use of probiotics is important therapy in infants with severe congenital anomalyPediatrics International, 2010
- Bifidobacterium Septicemia Associated with Postoperative Probiotic Therapy in a Neonate with OmphaloceleThe Journal of Pediatrics, 2010
- Probiotics Reduce the Risk of Necrotizing Enterocolitis in Preterm Infants: A Meta-AnalysisNeonatology, 2009
- Probiotic use in clinical practice: what are the risks?The American Journal of Clinical Nutrition, 2006